Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
Triciribine is an Akt activation inhibitor and a prodrug form of triciribine phosphate... more
Product information "Triciribine"
Triciribine is an Akt activation inhibitor and a prodrug form of triciribine phosphate (Cay-37985). It reduces levels of phosphorylated Akt1, -2, and -3 in Akt-overexpressing NIH3T3 cells when used at a concentration of 1 µM. Triciribine is selective for Akt1, -2, and -3 over a panel of seven other Akt-activating kinases at 1 µM. It reduces the proliferation of L1210 mouse leukemia cells when used at concentrations of 0.05, 0.2, and 1 µM. Triciribine (1 µM) induces cell cycle arrest at the G1 phase in L1210 cells. It reduces viral plaque formation in CEM-SS cells and human foreskin fibroblasts (HFFs) infected with HIV-1 and human cytomegalovirus (CMV), respectively (IC50s = 0.02 and 2 µM, respectively). It inhibits tumor proliferation in an OVCAR-3 ovarian cancer mouse xenograft model when administered at a dose of 1 mg/kg per day.Formal Name: 1,5-dihydro-5-methyl-1-beta-D-ribofuranosyl-1,4,5,6,8-pentaazaacenaphthylen-3-amine. CAS Number: 35943-35-2. Synonyms: API 2, NSC 154020, TCN, Tricyclic Nucleoside. Molecular Formula: C13H16N6O4. Formula Weight: 320.3. Purity: >98%. Formulation: (Request formulation change), A crystalline solid. Solubility: DMF: 25 mg/ml, DMSO: 30 mg/ml, Ethanol: 5 mg/ml, PBS (pH 7.2): 0.5 mg/ml. lambdamax: 295 nm. SMILES: OC[C@H]1O[C@H](C(O)C1O)n1cc2c(N)nn(C)c3ncnc1c23. InChi Code: InChI=1S/C13H16N6O4/c1-18-11-7-5(10(14)17-18)2-19(12(7)16-4-15-11)13-9(22)8(21)6(3-20)23-13/h2,4,6,8-9,13,20-22H,3H2,1H3,(H2,14,17)/t6-,8-,9-,13-/m1/s1. InChi Key: HOGVTUZUJGHKPL-HTVVRFAVSA-N.
Keywords: | API 2, NSC 154020, Tricyclic Nucleoside, 1,5-dihydro-5-methyl-1-beta-D-ribofuranosyl-1,2,5,6,8-pentaazaacenaphthylen-3-amine |
Supplier: | Cayman Chemical |
Supplier-Nr: | 10010237 |
Properties
Application: | Akt inhibitor |
MW: | 320.3 D |
Formula: | C13H16N6O4 |
Purity: | >98% |
Format: | Crystalline Solid |
Database Information
CAS : | 35943-35-2| Matching products |
KEGG ID : | K04456 | Matching products |
Handling & Safety
Storage: | -20°C |
Shipping: | +20°C (International: -20°C) |
Signal Word: | Danger |
GHS Hazard Pictograms: |
|
H Phrases: | H350 |
P Phrases: | P201, P202, P280, P308+P313, P405, P501 |
Caution
Our products are for laboratory research use only: Not for administration to humans!
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow.
more
You will get a certificate here
Viewed